During the past decade, Saules Seimos Medicinos Centras, Jsc conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 8 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 7 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saules Seimos Medicinos Centras, Jsc" #1 sponsor was "Pfizer" with 4 trials, followed by "Amgen" with 2 trials sponsored, "Bayer" with 2 trials sponsored, "AMAG Pharmaceuticals, Inc." with 1 trials sponsored and "Akorn, Inc." with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saules Seimos Medicinos Centras, Jsc" #1 collaborator was "Biomapas" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator, "Quintiles, Inc." with 1 trials as a collaborator and "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Saules Seimos Medicinos Centras, Jsc" are "Osteoarthritis, Knee" (3 trials), "Atrial Fibrillation" (2 trials), "Osteoarthritis, Hip" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "Chronic Pain" (1 trials). Many other conditions were trialed in "Saules Seimos Medicinos Centras, Jsc" in a lesser frequency.

Most popular intervention types in "Saules Seimos Medicinos Centras, Jsc" are "Drug" (14 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials) and "Asundexian matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saules Seimos Medicinos Centras, Jsc" are 15 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Saules Seimos Medicinos Centras, Jsc". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Saules Seimos Medicinos Centras, Jsc, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Saules Seimos Medicinos Centras, Jsc, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".